Dana-Farber Cancer Institute HandbookEdited by
- Arthur Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA
- Paul Lorigan, MB, FRCP, Senior Lecturer in Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments.
The book is aimed at trainee oncologists and general physicians who manage cancer patients outside of specialist centers.
Paperback, 168 Pages
The role of molecular probes and other markers in the diagnosis and characterization of malignancy
Lung cancer: aetiology, histopathology and clinical manifestation
Lung cancer treatment
Systemic and mucocutaneous reactions to chemotherapy